|
61 |
Abstracts of selected papers presented at the 29th annual meeting of the Japanese society of gastroenterology Kofu, Japan, November 5–7, 1987 Enthalten in Journal of gastroenterology Bd. 23, Nr. 4, date:8.1988: 461-492
|
|
|
62 |
Abstracts of Selected Papers Presented at the 28th Annual Meeting of the Japanese Society of Gastroenterology Kanazawa, Japan, October 1–3,1986 Enthalten in Journal of gastroenterology Bd. 22, Nr. 3, date:6.1987: 385-403
|
|
|
63 |
Proceedings of the international session of the 26th annual meeting October 18–20, 1984—Chiba, Japan Enthalten in Journal of gastroenterology Bd. 20, Nr. 3, date:6.1985: 273-298
|
|
|
64 |
A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma Enthalten in Investigational new drugs Bd. 32, 7.3.2014, Nr. 4, date:8.2014: 723-728
|
|
|
65 |
Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia Enthalten in Hepatology international Bd. 19, 17.2.2025, Nr. 1, date:2.2025: 1-69
|
|
|
66 |
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014 Enthalten in Hepatology international Bd. 8, 26.9.2014, Nr. 4, date:10.2014: 453-471
|
|
|
67 |
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update Enthalten in Hepatology international Bd. 13, 6.6.2019, Nr. 4, date:7.2019: 353-390
|
|
|
68 |
An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma Enthalten in Hepatology international Bd. 8, 25.7.2013, Nr. 1, date:1.2014: 94-103
|
|
|
69 |
APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis Enthalten in Hepatology international Bd. 16, 4.2.2022, Nr. 1, date:2.2022: 1-23
|
|
|
70 |
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024 Enthalten in Hepatology international Bd. 18, 21.11.2024, Nr. 6, date:12.2024: 1661-1683
|
|